Compounds > n-bromoacetyl-3,3',5-triiodothyronine
Page last updated: 2024-09-03

n-bromoacetyl-3,3',5-triiodothyronine and Cancer of Pituitary

n-bromoacetyl-3,3',5-triiodothyronine has been researched along with Cancer of Pituitary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, S; Horiuchi, R; Johnson, ML; Pastan, I; Willingham, MC1
Cheng, SY1

Other Studies

2 other study(ies) available for n-bromoacetyl-3,3',5-triiodothyronine and Cancer of Pituitary

ArticleYear
Affinity labeling of the plasma membrane 3,3',5-triiodo-L-thyronine receptor in GH3 cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1982, Volume: 79, Issue:18

    Topics: Affinity Labels; Animals; Binding, Competitive; Cell Line; Cell Membrane; Kinetics; Neoplasms, Experimental; Pituitary Neoplasms; Rats; Receptors, Cell Surface; Receptors, Thyroid Hormone; Triiodothyronine

1982
Structural similarities in the plasma membrane 3,3',5-triiodo-L-thyronine receptors from human, rat and mouse cultured cells. Analysis by affinity labeling.
    Endocrinology, 1983, Volume: 113, Issue:3

    Topics: Affinity Labels; Animals; Carcinoma; Cell Line; Cell Membrane; Endopeptidases; Fibroblasts; Humans; Mice; Pancreatic Elastase; Peptide Fragments; Pituitary Neoplasms; Rats; Receptors, Cell Surface; Receptors, Thyroid Hormone; Serine Endopeptidases; Triiodothyronine

1983